Literature DB >> 2893118

Criteria for severe aplastic anaemia.

B M Camitta.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 2893118     DOI： 10.1016/s0140-6736(88)90388-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Nontransplant therapy for bone marrow failure.

Authors:  Danielle M Townsley; Thomas Winkler
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

2.  Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.

Authors:  Danielle M Townsley; Phillip Scheinberg; Thomas Winkler; Ronan Desmond; Bogdan Dumitriu; Olga Rios; Barbara Weinstein; Janet Valdez; Jennifer Lotter; Xingmin Feng; Marie Desierto; Harshraj Leuva; Margaret Bevans; Colin Wu; Andre Larochelle; Katherine R Calvo; Cynthia E Dunbar; Neal S Young
Journal:  N Engl J Med       Date:  2017-04-20       Impact factor: 91.245

3.  Evaluation of treatment responses and colony-forming progenitor cells in 50 patients with aplastic anemia after immunosuppressive therapy or hematopoietic stem cell transplantation: a single-center experience.

Authors:  Wolfgang Füreder; Andrea Paulitsch-Buckingham; Werner Rabitsch; Eva Jäger; Ilse Schwarzinger; Wolfgang R Sperr; Peter Valent
Journal:  Wien Klin Wochenschr       Date:  2014-01-18       Impact factor: 1.704

4.  Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia.

Authors:  Xin Zhao; Xingmin Feng; Zhijie Wu; Thomas Winkler; Ronan Desmond; Matthew Olnes; Bogdan Dumitriu; Danielle M Townsley; Cynthia E Dunbar; Neal S Young
Journal:  Exp Hematol       Date:  2017-09-20       Impact factor: 3.084

5.  Outcome of bone marrow transplantation in acquired and inherited aplastic anaemia in the Republic of Ireland.

Authors:  A Piccin; A O'Marcaigh; O Smith; J O'Riordan; M Crowley; E Vandenberg; N Gardiner; S McCann
Journal:  Ir J Med Sci       Date:  2005 Jul-Sep       Impact factor: 1.568

6.  Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome.

Authors:  Jean Donadieu; Odile Fenneteau; Blandine Beaupain; Sandrine Beaufils; Florence Bellanger; Nizar Mahlaoui; Anne Lambilliotte; Nathalie Aladjidi; Yves Bertrand; Valérie Mialou; Christine Perot; Gérard Michel; Fanny Fouyssac; Catherine Paillard; Virginie Gandemer; Patrick Boutard; Jacques Schmitz; Alain Morali; Thierry Leblanc; Christine Bellanné-Chantelot
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

7.  Impairment of hematopoietic stem cell niches in patients with aplastic anemia.

Authors:  Liangliang Wu; Wenjian Mo; Yuping Zhang; Hui Deng; Yumiao Li; Ruiqing Zhou; Lu Zhang; Shiyi Pan; Shunqing Wang
Journal:  Int J Hematol       Date:  2015-10-06       Impact factor: 2.490

8.  Eltrombopag added to immunosuppression for children with treatment-naïve severe aplastic anaemia.

Authors:  Emma M Groarke; Bhavisha A Patel; Fernanda Gutierrez-Rodrigues; Olga Rios; Jennifer Lotter; Daniela Baldoni; Annie St Pierre; Ruba Shalhoub; Colin O Wu; Danielle M Townsley; Neal S Young
Journal:  Br J Haematol       Date:  2021-01-07       Impact factor: 8.615

9.  Cyclosporine Monotherapy in Pediatric Patients With Non-severe Aplastic Anemia: A Retrospective Analysis.

Authors:  Hongmin Li; Lingling Fu; Bixi Yang; Hui Chen; Jie Ma; Runhui Wu
Journal:  Front Med (Lausanne)       Date:  2022-03-07

10.  [Efficacy of stanozolol and danazol in the treatment of non-severe aplastic anemia and their effects on CD4(+)CD25(+)Foxp3(+) regulatory T cells].

Authors:  H M Li; Z B Long; T Wang; B Han
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.